phloroglucinol has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, CP; Chang, BE; Chang, HH; Chang, MC; Chou, HY; Jeng, JH; Wang, TM; Yeung, SY | 1 |
1 other study(ies) available for phloroglucinol and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Antiplatelet effect of phloroglucinol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Interleukin-1beta; Male; Mice; Mice, Inbred ICR; p38 Mitogen-Activated Protein Kinases; Phloroglucinol; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Reactive Oxygen Species; Signal Transduction; Thromboxane A2 | 2012 |